Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers

Nicholas J. Ashton*, Marc Suarez-Calvet, Amanda Heslegrave, Abdul Hye, Cristina Razquin, Pau Pastor, Raquel Sanchez-Valle, Jose L. Molinuevo, Pieter Jelle Visser, Kaj Blennow, Angela K. Hodges, Henrik Zetterberg

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number94
Number of pages7
JournalAlzheimer's Research & Therapy
Volume11
Issue number1
DOIs
Publication statusPublished - 28 Nov 2019

Keywords

  • Alzheimer's disease
  • sTREM2
  • Blood
  • Biomarkers
  • Neurofilament light chain
  • ALZHEIMERS-DISEASE
  • CEREBROSPINAL-FLUID
  • POTENTIAL BIOMARKER
  • MYELOID CELLS-2
  • PROTEIN
  • BLOOD
  • NEURODEGENERATION
  • IDENTIFICATION
  • ASSOCIATION
  • EXPRESSION

Cite this

Ashton, N. J., Suarez-Calvet, M., Heslegrave, A., Hye, A., Razquin, C., Pastor, P., Sanchez-Valle, R., Molinuevo, J. L., Visser, P. J., Blennow, K., Hodges, A. K., & Zetterberg, H. (2019). Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers. Alzheimer's Research & Therapy, 11(1), [94]. https://doi.org/10.1186/s13195-019-0545-5